Pressure Sore Prevention Strategy for the Prone Position
Launched by UNIVERSITY HOSPITAL, CAEN · Jun 3, 2024
Trial Information
Current as of February 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Hydrocellular dressings will be compared with hydrocolloid dressings to determine their effectiveness in preventing pressure ulcers during ventral decubitus in intensive care. The dressings will cover the skin in at-risk areas, and caregivers will assess whether or not pressure sores develop in these areas after prone positioning. The stage of these pressure sores will also be assessed.
The time spent on each strategy and the cost per strategy will also be evaluated. Dressings will be applied for the entire period during which participants are placed in the prone position. If they develop ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Major patient
- • Moderate to severe acute respiratory distress syndrom (Arterial oxygen pressure /Inspired Fraction of oxygen ratio \< 200) requiring at least one VD session.
- • Affiliated to the French social security system
- • Sedated patient on mechanical ventilation
- Exclusion Criteria:
- • Pregnant or breast-feeding women
- • Patient under guardianship or trusteeship
- • Minor patients
Trial Officials
Agathe Hamelin
Principal Investigator
CHU Caen
About University Hospital, Caen
The University Hospital of Caen is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent center for medical education and patient care in Normandy, France, it integrates cutting-edge scientific inquiry with compassionate clinical practice. The hospital collaborates with multidisciplinary teams to conduct rigorous studies aimed at improving treatment outcomes across various medical specialties. By fostering a collaborative environment, the University Hospital of Caen plays a pivotal role in translating research findings into effective therapeutic strategies, ultimately enhancing patient care and contributing to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0